Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev












Signal Accounts for Members
All Signal Accounts
All Contests


USA Treasury's Bessent: 'Wholeheartedly' Supports Trump's Call For Cap On Credit Card Interest Rates At 10%
According To The U.S. Energy Information Administration (EIA), For The Week Ending January 30, Total U.S. Natural Gas Inventories Were 2.463 Trillion Cubic Feet, A Decrease Of 360 Billion Cubic Feet From The Previous Week, An Increase Of 41 Billion Cubic Feet From The Same Period Last Year, Representing A Year-on-Year Increase Of 1.7%, And 27 Billion Cubic Feet Lower Than The 5-year Average, Representing A Decrease Of 1.1%
US Treasury Secretary Bessant: Whether To Sue Federal Reserve Chairman Nominee Warsh Over Interest Rate Issues Will Be Decided By President Trump
Colombia Public Credit Director: We Have Around 10 Billion Dollars In Treasury And Will Likely Continue To Build Up Reserves
U.S. Senate Majority Leader John Thune: The Senate’s Request For Funding For The Department Of Homeland Security (DhS) Is “unrealistic.”
Colombia Public Credit Director Projects Domestic Debt Issuance Of 85.2 Trillion Pesos In 2026
U.S. Treasury Secretary Bessenter Reiterated His Statement Made On February 4 Before The House Financial Services Committee At A Hearing Of The Senate Banking Committee
[Ethereum Breaks Below $2000 After 273 Days, Down 8.2% In 24 Hours] February 5Th, According To Htx Market Data, Ethereum Fell Below $2000 After 273 Days, With A 24-Hour Decrease Of 8.2%, Marking The First Time Since May 8, 2025
U.S. Ambassador To Poland Tom Rose Announced That He Would Sever All Ties With Polish Sejm Speaker Włodzimierz Czarzasty. The Diplomat Claimed That The Speaker's Remarks Were A "direct Offense" To U.S. President Trump And Detrimental To Polish Prime Minister Tusk, Who Has Called Trump "Dad," And His Government's "excellent Relationship" With The U.S
U.S. Department Of Defense: The United States And Russia Have Agreed To Resume Military Dialogue
The U.S. Global Supply Chain Stress Index For January Was 0.41, Revised From 0.51 To 0.54 In The Previous Month
Qatar Sets March Marine Crude Osp At Oman/Dubai Minus $1.00/Bbl, Land Crude Osp At Oman/Dubai Plus $0.80/Bbl
Shell CEO Says Oil Market Supply Slightly Long, Balanced By Geopolitical Risk Like Venezuela And Iran

Japan 30-Year JGB Auction YieldA:--
F: --
P: --
Indonesia Annual GDP GrowthA:--
F: --
P: --
Indonesia GDP YoY (Q4)A:--
F: --
P: --
France Industrial Output MoM (SA) (Dec)A:--
F: --
Italy IHS Markit Construction PMI (Jan)A:--
F: --
P: --
Euro Zone IHS Markit Construction PMI (Jan)A:--
F: --
P: --
Germany Construction PMI (SA) (Jan)A:--
F: --
P: --
Italy Retail Sales MoM (SA) (Dec)A:--
F: --
P: --
U.K. Markit/CIPS Construction PMI (Jan)A:--
F: --
P: --
France 10-Year OAT Auction Avg. YieldA:--
F: --
P: --
Euro Zone Retail Sales YoY (Dec)A:--
F: --
Euro Zone Retail Sales MoM (Dec)A:--
F: --
U.K. BOE MPC Vote Cut (Feb)A:--
F: --
P: --
U.K. BOE MPC Vote Hike (Feb)A:--
F: --
P: --
U.K. BOE MPC Vote Unchanged (Feb)A:--
F: --
P: --
U.K. Benchmark Interest RateA:--
F: --
P: --
MPC Rate Statement
U.S. Challenger Job Cuts (Jan)A:--
F: --
P: --
U.S. Challenger Job Cuts MoM (Jan)A:--
F: --
P: --
U.S. Challenger Job Cuts YoY (Jan)A:--
F: --
P: --
Bank of England Governor Bailey held a press conference on monetary policy.
Euro Zone ECB Marginal Lending RateA:--
F: --
P: --
Euro Zone ECB Deposit RateA:--
F: --
P: --
Euro Zone ECB Main Refinancing RateA:--
F: --
P: --
ECB Monetary Policy Statement
U.S. Weekly Initial Jobless Claims (SA)A:--
F: --
P: --
U.S. Initial Jobless Claims 4-Week Avg. (SA)A:--
F: --
P: --
U.S. Weekly Continued Jobless Claims (SA)A:--
F: --
ECB Press Conference
U.S. JOLTS Job Openings (SA) (Dec)A:--
F: --
U.S. EIA Weekly Natural Gas Stocks ChangeA:--
F: --
P: --
BOC Gov Macklem Speaks
Mexico Policy Interest Rate--
F: --
P: --
U.S. Weekly Treasuries Held by Foreign Central Banks--
F: --
P: --
Reserve Bank of Australia Governor Bullock testified before Parliament.
India Benchmark Interest Rate--
F: --
P: --
India Cash Reserve Ratio--
F: --
P: --
India Repo Rate--
F: --
P: --
India Reverse Repo Rate--
F: --
P: --
Japan Leading Indicators Prelim (Dec)--
F: --
P: --
Germany Industrial Output MoM (SA) (Dec)--
F: --
P: --
Germany Exports MoM (SA) (Dec)--
F: --
P: --
U.K. Halifax House Price Index YoY (SA) (Jan)--
F: --
P: --
U.K. Halifax House Price Index MoM (SA) (Jan)--
F: --
P: --
France Trade Balance (SA) (Dec)--
F: --
P: --
Canada Leading Index MoM (Jan)--
F: --
P: --
India Deposit Gowth YoY--
F: --
P: --
Canada Employment (SA) (Jan)--
F: --
Canada Full-time Employment (SA) (Jan)--
F: --
Canada Part-Time Employment (SA) (Jan)--
F: --
Canada Unemployment Rate (SA) (Jan)--
F: --
P: --
Canada Labor Force Participation Rate (SA) (Jan)--
F: --
P: --
U.S. Unemployment Rate (SA) (Jan)--
F: --
P: --
U.S. Nonfarm Payrolls (SA) (Jan)--
F: --
P: --
U.S. Average Hourly Wage YoY (Jan)--
F: --
P: --
U.S. Average Hourly Wage MoM (SA) (Jan)--
F: --
P: --
U.S. U6 Unemployment Rate (SA) (Jan)--
F: --
P: --
U.S. Manufacturing Employment (SA) (Jan)--
F: --
P: --
U.S. Labor Force Participation Rate (SA) (Jan)--
F: --
P: --
U.S. Average Weekly Working Hours (SA) (Jan)--
F: --
P: --
U.S. Private Nonfarm Payrolls (SA) (Jan)--
F: --
P: --

















































No matching data
View All

No data
Hainan Huluwa Pharmaceutical Group received approval from China's National Medical Products Administration to revise some information for cefotaxime sodium for injection, according to a Shanghai bourse filing on Friday.
The amendments included changing drug quality standards, and packaging materials and containers in direct contact with the drug.
The approval came after the drug passed the regulator's quality and efficacy consistency evaluation, the Chinese pharmaceutical company said.
Hainan Huluwa Pharmaceutical Group obtained the drug registration certificate for Cefprozil for oral suspension from China's National Medical Products Administration, according to a Shanghai bourse filing on Friday.
The drug was originally developed by Bristol-Myers Squibb to treat mild to moderate infections caused by susceptible bacteria.
The Chinese pharmaceutical company invested 4.9 million yuan into the research and development of the drug, the filing said.
The company's shares rose over 2% in recent trade.
Hainan Huluwa Pharmaceutical Group received approval from the Chinese drug administration to begin clinical trials on Feire Kechuan Granules, according to a Shanghai bourse disclosure on Thursday.
The Chinese pharmaceutical company will test the traditional Chinese medicine's new formula, which was expanded to include the treatment of heat toxins in lungs caused by influenza.
The company's shares dropped over 3% in recent trade.
Hainan Huluwa Pharmaceutical Group received approval from the National Medical Products Administration (NMPA) to register Esomeprazole Sodium Injection, according to a Wednesday filing with the Shanghai Bourse.
The drug, used for treating conditions like gastroesophageal reflux disease (GERD) and gastric ulcers, is approved in 20mg and 40mg dosages.
Hainan Huluwa Pharmaceutical Group received a drug registration certificate from China's National Medical Products Administration (NMPA) for its inhalable salbutamol sulfate solution, according to a Thursday filing with the Shanghai bourse
The medication is approved for treating chronic bronchospasm unresponsive to traditional treatments and severe acute asthma attacks.
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.
Not Logged In
Log in to access more features
Log In
Sign Up